Publications of Tanja M. Brueckl
All genres
Journal Article (17)
2022
Journal Article
Predicting treatment outcome in depression: an introduction into current concepts and challenges. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2022)
Journal Article
215, 173371 (2022)
Early adversity as the prototype gene x environment interaction in mental disorders? PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 2021
Journal Article
46 (7), pp. 1272 - 1282 (2021)
Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings. NEUROPSYCHOPHARMACOLOGY
Journal Article
160, 107923 (2021)
Imagery of negative interpersonal experiences influence the neural mechanisms of social interaction. NEUROPSYCHOLOGIA
Journal Article
44, p. S45 - S45 (2021)
Latent class growth modeling reveals two distinct pupillometric response profiles in a working memory task. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Journal Article
7 (5), eabe4497 (2021)
Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation. SCIENCE ADVANCES
Journal Article
67 (2), pp. 224 - 225 (2021)
Evidence for a prothrombotic State in Patients with remitted Depression. ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE 2020
Journal Article
10 (12), 906 (2020)
Pupil Dilation during Reward Anticipation Is Correlated to Depressive Symptom Load in Patients with Major Depressive Disorder. BRAIN SCIENCES
Journal Article
20 (1), 213 (2020)
The biological classification of mental disorders (BeCOME) study: a protocol for an observational deep-phenotyping study for the identification of biological subtypes. BMC PSYCHIATRY
Journal Article
31, pp. S42 - S43 (2020)
Cortical thickness variation in major depressive disorder is indicative of symptom profiles: a data-driven approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Journal Article
129, 103610 (2020)
No robust differences in fear conditioning between patients with fear-related disorders and healthy controls. BEHAVIOUR RESEARCH AND THERAPY
Journal Article
31, p. S62 - S62 (2020)
Developing a digital decision support system for an early estimation of treatment response in depression. EUROPEAN NEUROPSYCHOPHARMACOLOGY
Journal Article
21 (10), pp. 766 - 774 (2020)
Evidence for an enhanced procoagulant state in remitted major depression. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Journal Article
54 (8), pp. 611 - 618 (2020)
Acute Stress-Induced Coagulation Activation in Patients With Remitted Major Depression Versus Healthy Controls and the Role of Stress-Specific Coping. ANNALS OF BEHAVIORAL MEDICINE 2019
Journal Article
20 (3), 485 (2019)
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. International Journal of Molecular Sciences
Journal Article
20 (3), 485 (2019)
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Journal Article
29, p. S256 - S256 (2019)
Data-driven clustering of cortical thickness reveals stable major depressive disorder biotypes associated with treatment response. EUROPEAN NEUROPSYCHOPHARMACOLOGY Meeting Abstract (4)
2021
Meeting Abstract
128 (11), p. 1773 - 1773. (2021)
Patient stratification based on pupillometric response profiles and its brain correlates in affective and anxiety disorders. In JOURNAL OF NEURAL TRANSMISSION, 2020
Meeting Abstract
21 (10), pp. 766 - 774. (2020)
Evidence for an enhanced procoagulant state in remitted major depression. In WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2019
Meeting Abstract
66 (1), p. 119 - 119. (2019)
Evidence of a prothrombotic Condition in Patients with a remitted Depression. In ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE,